Less than one in 10 people eligible to benefit from weight-loss injections including Wegovy can access them, states the World Health Organization as it releases its first guidance on the medications.
Considering more than one billion individuals worldwide currently living with obesity, it is advocating for broader and more equitable access to GLP-1 medication.
Per projections, more than two billion are projected to be obese by 2030 unless action is taken.
"Our latest guidelines recognises that obesity is a long-term condition that can be addressed with holistic and continuous treatment," remarked its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and logistical bottlenecks are key obstacles to widespread access to the jabs that can aid individuals in losing considerable body mass, says the body.
Weight-Loss Drug Shortage
Even in the present best projected case, the supply of GLP-1 therapies might only reach about 100 million people – fewer than 10% of eligible patients, as stated by the health organization.
The advice calls on countries and companies to widen access, via strategies such as voluntary licensing.
The intellectual property rights on the active ingredient – the core ingredient of a leading brand – is scheduled to end in a number of nations in 2026.
The Way Weight-Loss Injections Operate
The injections imitate a biological compound to delay gastric emptying, suppress the appetite and increase feelings of fullness so people consume fewer calories.
Individuals typically begin shedding pounds in the initial weeks of beginning the weekly injections.
Studies points to users may regain a significant portion a year later of discontinuing the treatment, because their usual hunger come back.
Being above a healthy weight elevates your chance for developing diseases, including diabetes, cardiovascular issues, stroke, and some malignancies.
Excess weight affects people in countries worldwide and was associated with over three and a half million deaths worldwide in 2024, according to the WHO.
